Multiple Sclerosis News Today Forums Forums Trials and Research Good News Possibly for Spascisty Sufferers

  • Good News Possibly for Spascisty Sufferers

    Posted by john-connor on July 2, 2020 at 12:23 pm

    Our news section today reports on a new drug, Arbaclofen ER – an extended release formulation of arbaclofen, the R isomer of baclofen, that leverages our proprietary Osmodex® drug delivery system and is being studied for the treatment of spasticity resulting from multiple sclerosis.
    The company are applying to the US Food and Drug Administration for approval.
    I only recently started using Baclofen and for me it has been brilliant.
    If there’s an even better drug than that, hurrah.
    Of course it needs to be approved and for me in the UK it would then have to be separately approved then get through our rather complex NICE process.

    john-connor replied 3 years, 9 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.